The inhibitory effect of 152 was found to be regulated by the inactivation of the NF-κB, MAPK, and TLR4/MyD88 signaling pathways, indicating that 152 presented potential anti-inflammatory candidates for the treatment of neurodegenerative diseases [58]. The gene discussed is MYD88; the disease is neurodegenerative disease.